Cite
HARVARD Citation
Grosman, B. et al. (2021). Fast-acting insulin aspart (Fiasp®) improves glycemic outcomes when used with MiniMedTM 670G hybrid closed-loop system in simulated trials compared to NovoLog®. Computer methods and programs in biomedicine. p. . [Online].